OR WAIT null SECS
December 04, 2017
The acquisition deepens Astellas’ involvement in the development of a pipeline of therapeutics focused on mitochondrial function.
December 02, 2017
Attracting and retaining qualified bio/pharma experts demands a mix of recognition, rewards, and opportunities.
Is pharma up to the task of developing knowledgeable, motivated employees?
Amid business and regulatory uncertainty, bio/pharma experts reveal opinions on salary, recognition, and training.
December 01, 2017
Lonza has entered into strategic license agreements for exclusive rights to a gene-therapy platform for developing treatments for hearing and balance disorders.
November 28, 2017
The acquisition gives GE Healthcare access to a nanofiber-based platform purification technology that can offer improvements in biopharmaceutical productivity.
The joint venture will focus on the discovery, development, and commercialization of potential new drugs for the global market as well as speed delivery of new medicines to China.
November 27, 2017
In the wake of generic-drug pricing pressure and declining revenues, Teva has restructured its commercial business and made executive leadership changes.
November 21, 2017
Following a vote by member states in favor of Amsterdam as the agency’s new headquarters, the relocation will take place over the next 16 months, with operations expected to start up in March 2019.
November 16, 2017
As part of the deal, J&J’s Janssen will pay an upfront payment of $50 million to research, develop, and commercialize up to six bispecific antibodies.